PR-104
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for PR-104, covering 2011-03-02 to 2013-08-23. Get the full timeline:
Most recent: Clinical Trial Update: Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]